0001209191-18-052615.txt : 20180928
0001209191-18-052615.hdr.sgml : 20180928
20180928174351
ACCESSION NUMBER: 0001209191-18-052615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180927
FILED AS OF DATE: 20180928
DATE AS OF CHANGE: 20180928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hargreaves Glenn
CENTRAL INDEX KEY: 0001554374
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37550
FILM NUMBER: 181095168
MAIL ADDRESS:
STREET 1: 701 COOL SPRINGS BLVD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quorum Health Corp
CENTRAL INDEX KEY: 0001650445
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 474725208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1573 MALLORY LANE
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
BUSINESS PHONE: 615-221-1400
MAIL ADDRESS:
STREET 1: 1573 MALLORY LANE
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-27
0
0001650445
Quorum Health Corp
QHC
0001554374
Hargreaves Glenn
1573 MALLORY LANE
SUITE 100
BRENTWOOD
TN
37027
0
1
0
0
SVP & Chief Accounting Officer
Common stock, par value $0.0001 per share
2018-09-27
4
J
0
75000
0.00
D
0
D
Common stock, par value $0.0001 per share
2018-09-27
4
A
0
75000
0.00
A
75000
D
On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the August 24, 2018 award of 75,000 shares of the Issuer's restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 75,000 shares of restricted common stock as an inducement award outside the Issuer's 2016 Stock Award Plan in reliance on the employment inducement exemption to shareholder approval provided under the New York Stock Exchange's Listed Company Manual Rule 303A.08.
50% of the award is time-vested restricted stock and vests in three equal installments beginning on the first anniversary of August 24, 2018, and 50% of the award is performance-based restricted common stock and vests, if at all, over a two-year performance period based on the achievement of target metrics.
/s/ R. Harold McCard, Jr., Attorney in Fact for Glenn Hargreaves
2018-09-28